Director of New Venture and Entrepreneurship, Australian National University
| Role | Organisation | Sources |
|---|---|---|
| Director (former) | Kinoxis Therapeutics | Uniseed, Startup Daily |
| Director of New Venture and Entrepreneurship (former) | Australian National University | Startup Daily |
| Principal (former) | Main Sequence Ventures | Startup Daily (23 Sep 2026), Startup Daily (19 Mar 2024), Main Sequence Ventures team page |
Stories naming Dr Elaine Stead. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Kinoxis completed a $6.75 million round with new backer MainSequence and won a $2.5 million government-funded CUREator+ grant for dementia and pain drug development; MainSequence's Elaine Stead joins the board.
Also Startup Daily·Startup Daily·Dealroom·This Week in Australian Startups·Dynamic Business
Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.
Weekly tech wrap: cloud-market trends, Tiger Global's cheques into Stake, Shippit and Carma, new VC funds, several acquisitions, grocery delivery startups Send and Quicko collapsing, and Elaine Stead joining M8 Ventures.
Also Startup Daily